Absorbable Heart Stent Market Highlights

The absorbable heart stent market share is expected to reach USD 0.44 Billion by 2032 at 13.2% CAGR during the forecast period 2023-2032. On the other hand, there are few hurdles in the growth of this market. One of the biggest players in absorbable stent market, Abbott Vascular, has stopped manufacturing of its interventional cardiology product ABSORB GT. The company has terminated sales and operations related to this product in all the countries across the world due to the increased heart attack incidences with the use of its product. This major development may result in thwarting the growth of the market soon. However, market may regain its growth if the company resolves the issue in time and come up with better product in the market.

In 2015, according to WHO reports, globally, the prevalence of cardiac disease in adults aged 18 and above was around 24.1% in men and 20.1% in women largely from low- and middle-income countries. Increasing unhealthy habits, lack of physical exercise and increasing prevalence of cardiac diseases contributed growth to the market. According to American college of cardiology, absorbable heart stent will replace the conventional metal stents in coming years. This is due to number of advantages of using absorbable heart stents. Most bioresorbable stents are made of polylactic acid. It is a naturally dissolvable material used in medical implants. Demand for absorbable heart stents is increasing due to advancement in technology of developing heart stents and increase in number of cardiac surgeries.

Segmentation:

Global absorbable heart stent market outlook research report has been segmented based on material used for bio absorbable stents which includes metal and polymer.

The end users are hospitals, cardiac canters, research institutes and other users.

Market Players:

Key players in absorbable heart stent market are Abbott Laboratories (U.S.), Biotronik (Germany), Arterial Remodeling Technologies SA (France), Amaranth Medical Inc. (U.S.), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.).

Regional Analysis

The Absorbable Heart Stent Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas dominates the Absorbable Heart Stent Market due to high healthcare expenditures, a well-developed healthcare sector, and increasing prevalence of the coronary artery diseases. Moreover, the presence of developed economies like the U.S. and Canada facilitates the market growth during the forecast period.  Europe stands second in the Absorbable Heart Stent Market and is estimated to be followed by Asia Pacific. Huge patient population, increasing research and development expenses, and increasing awareness are the major drives the market growth within Europe. Asia Pacific region is estimated to be the fastest growing for the Global Absorbable Heart Stent Market. This can be attributed to the presence of developing economies like India and China, a developing healthcare sector, growing healthcare industries within the region. However, the Middle East & Africa is estimated to hold the least market share of the market owing to the presence poor economies and stringent government policies within the African region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013